Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Down 11.4% in December

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a significant drop in short interest in December. As of December 15th, there was short interest totalling 2,119,600 shares, a drop of 11.4% from the November 30th total of 2,393,200 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Genomma Lab Internacional Price Performance

Shares of Genomma Lab Internacional stock remained flat at $1.27 on Wednesday. Genomma Lab Internacional has a 52 week low of $0.79 and a 52 week high of $1.28. The stock has a 50-day moving average price of $1.23 and a 200 day moving average price of $1.10.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.